van der Put Robert M F, de Haan Alex, van den IJssel Jan G M, Hamidi Ahd, Beurret Michel
Unit Product Development, Institute for Translational Vaccinology (Intravacc(1)), P.O. Box 450, 3720 AL Bilthoven, The Netherlands.
Unit Product Development, Institute for Translational Vaccinology (Intravacc(1)), P.O. Box 450, 3720 AL Bilthoven, The Netherlands.
Vaccine. 2015 Nov 27;33(48):6908-13. doi: 10.1016/j.vaccine.2014.07.028. Epub 2014 Jul 19.
Due to the rapidly increasing introduction of Haemophilus influenzae type b (Hib) and other conjugate vaccines worldwide during the last decade, reliable and robust analytical methods are needed for the quantitative monitoring of intermediate samples generated during fermentation (upstream processing, USP) and purification (downstream processing, DSP) of polysaccharide vaccine components. This study describes the quantitative characterization of in-process control (IPC) samples generated during the fermentation and purification of the capsular polysaccharide (CPS), polyribosyl-ribitol-phosphate (PRP), derived from Hib. Reliable quantitative methods are necessary for all stages of production; otherwise accurate process monitoring and validation is not possible. Prior to the availability of high performance anion exchange chromatography methods, this polysaccharide was predominantly quantified either with immunochemical methods, or with the colorimetric orcinol method, which shows interference from fermentation medium components and reagents used during purification. Next to an improved high performance anion exchange chromatography-pulsed amperometric detection (HPAEC-PAD) method, using a modified gradient elution, both the orcinol assay and high performance size exclusion chromatography (HPSEC) analyses were evaluated. For DSP samples, it was found that the correlation between the results obtained by HPAEC-PAD specific quantification of the PRP monomeric repeat unit released by alkaline hydrolysis, and those from the orcinol method was high (R(2)=0.8762), and that it was lower between HPAEC-PAD and HPSEC results. Additionally, HPSEC analysis of USP samples yielded surprisingly comparable results to those obtained by HPAEC-PAD. In the early part of the fermentation, medium components interfered with the different types of analysis, but quantitative HPSEC data could still be obtained, although lacking the specificity of the HPAEC-PAD method. Thus, the HPAEC-PAD method has the advantage of giving a specific response compared to the orcinol assay and HPSEC, and does not show interference from various components that can be present in intermediate and purified PRP samples.
由于在过去十年中全球范围内b型流感嗜血杆菌(Hib)和其他结合疫苗的引入迅速增加,因此需要可靠且强大的分析方法来定量监测多糖疫苗成分发酵(上游加工,USP)和纯化(下游加工,DSP)过程中产生的中间样品。本研究描述了源自Hib的荚膜多糖(CPS)、多聚核糖基核糖醇磷酸(PRP)在发酵和纯化过程中产生的过程控制(IPC)样品的定量表征。可靠的定量方法对于生产的所有阶段都是必要的;否则,准确的过程监测和验证是不可能的。在高效阴离子交换色谱法出现之前,这种多糖主要通过免疫化学方法或比色法邻苯二酚法进行定量,而这两种方法都显示出受到发酵培养基成分和纯化过程中使用的试剂的干扰。除了使用改进的梯度洗脱的高效阴离子交换色谱 - 脉冲安培检测(HPAEC - PAD)方法外,还评估了邻苯二酚法和高效尺寸排阻色谱(HPSEC)分析。对于DSP样品,发现通过HPAEC - PAD对碱性水解释放的PRP单体重复单元进行特异性定量所获得的结果与邻苯二酚法的结果之间的相关性很高(R(2)=0.8762),而HPAEC - PAD与HPSEC结果之间的相关性较低。此外,对USP样品的HPSEC分析产生了与HPAEC - PAD获得的结果惊人可比的结果。在发酵早期,培养基成分干扰了不同类型的分析,但尽管缺乏HPAEC - PAD方法的特异性,仍可获得定量的HPSEC数据。因此,与邻苯二酚法和HPSEC相比,HPAEC - PAD方法具有给出特异性响应的优势,并且不会受到中间和纯化的PRP样品中可能存在的各种成分的干扰。